Please assess the completion status of the following clinical trial:

Trial Title: PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Either sex, age ≥ 18 years~* Diagnosis of mesothelioma by multi-disciplinary team (MDT). All histological subtypes are eligible for the trial~* ECOG performance status 0-2 (Appendix C)~* Inoperable disease or operable disease in patients unsuitable for surgery as decided by a MDT~* Chest wall intervention with video-assisted thoracoscopy (VATS), open surgical biopsy (mini-thoracotomy), local anaesthetic thoracoscopy or chest drain~* Able to start radiotherapy within 42 days (6 weeks) of the most recent chest wall procedure~* Chest wall intervention scar visible at time of randomisation~* Radiotherapy target volume acceptable by the local radiotherapist~* Patients enrolled on other clinical trials could be considered after discussion with the chief investigators~Exclusion Criteria:~* Patients who underwent a thoracotomy (as large thoracotomy scars may not be adequately covered by this radiotherapy technique)~* Previous radiotherapy to the region of the chest wall intervention site~* Indwelling pleural catheter in-situ at the intervention site~* Patients currently receiving chemotherapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PIT Arm (Type: EXPERIMENTAL): None
- No PIT Arm (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).